Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy. | Neuro Oncol | 2023 | 35608632 | PubTator, text mining | PubMed |
| circRNAs in drug resistance of breast cancer. | Oncol Res | 2022 | 37304411 | PubTator, text mining | PubMed |
| Whole exome sequencing revealed novel pathogenic variants in Vietnamese patients with FEVR. | Mol Vis | 2022 | 37089697 | PubTator, text mining | PubMed |
| Identification of Core Genes Shared by Endometrial Cancer and Ovarian Cancer Using an Integrated Approach. | Cell Mol Biol (Noisy-le-grand) | 2022 | 36905262 | PubTator, text mining | PubMed |
| KIF11 As a Potential Pan-Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic Responses. | Oxid Med Cell Longev | 2022 | 36742345 | PubTator, text mining | PubMed |
| Recent applications of computational methods to allosteric drug discovery. | Front Mol Biosci | 2022 | 36710877 | PubTator, text mining | PubMed |
| Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma. | Front Genet | 2022 | 36699449 | PubTator, text mining | PubMed |
| KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status. | Front Oncol | 2022 | 36686769 | PubTator, text mining | PubMed |
| Identification of kinases activated by multiple pro-angiogenic growth factors. | Front Pharmacol | 2022 | 36686695 | PubTator, text mining | PubMed |
| Gastric infiltration of hepatic sarcomatoid carcinoma: A case report and literature review. | Front Surg | 2022 | 36684166 | PubTator, text mining | PubMed |
| A Counterintuitive Neutrophil-Mediated Pattern in COVID-19 Patients Revealed through Transcriptomics Analysis. | Viruses | 2022 | 36680144 | PubTator, text mining | PubMed |
| Thymus musilii Velen. Methanolic Extract: In Vitro and In Silico Screening of Its Antimicrobial, Antioxidant, Anti-Quorum Sensing, Antibiofilm, and Anticancer Activities. | Life (Basel) | 2022 | 36676011 | PubTator, text mining | PubMed |
| The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer. | Biomolecules | 2022 | 36671447 | PubTator, text mining | PubMed |
| Pan-cancer analysis of DEPDC1 as a candidate prognostic biomarker and associated with immune infiltration. | Ann Transl Med | 2022 | 36660720 | PubTator, text mining | PubMed |
| Identification of immune-related genes and development of a prognostic model in mantle cell lymphoma. | Ann Transl Med | 2022 | 36660618 | PubTator, text mining | PubMed |
| Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling. | Int J Mol Sci | 2022 | 36613607 | PubTator, text mining | PubMed |
| Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. | Cancers (Basel) | 2022 | 36612248 | PubTator, text mining | PubMed |
| Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent. | Cancers (Basel) | 2022 | 36612203 | PubTator, text mining | PubMed |
| The Effects of Heat Stress on the Transcriptome of Human Cancer Cells: A Meta-Analysis. | Cancers (Basel) | 2022 | 36612111 | PubTator, text mining | PubMed |
| An ultrasensitive, rapid and portable method for screening oseltamivir-resistant virus based on CRISPR/Cas12a combined with immunochromatographic strips. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 36604145 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=31